- INSURERS SAY THEY WON'T PAY FOR PREVENTABLE MEDICAL ERRORS. Smerd, Jeremy // Workforce Management;2/4/2008, Vol. 87 Issue 2, p4
The article reports that private insurance companies are looking for ways to stop paying hospitals for preventable medical errors. This follows the decision of the U.S. Centers for Medicare & Medicaid Services (CMS) to stop reimbursing hospitals for the added cost of care to treat eight...
- CMS Delays 5010 Enforcement, Notifies of Missed Claims. // ACA News (American Chiropractic Association);May2012, Vol. 8 Issue 5, p9
No abstract available.
- CMS Demonstrations Target Common Factors Leading to Improper Payment. // American Family Physician;12/15/2011, Vol. 84 Issue 12, following p1409
The article announces the launch of three demonstration programs targeted at minimizing improper payments by the U.S. Centers for Medicare and Medicaid Services (CMS) in December 2011.
- Medicaid DSH final rule. // AHA News;9/27/2013, Vol. 49 Issue 19, p3
The article reports on the final methodology rule issued by the Centers for Medicare & Medicaid Services (CMS) in September 2013, which establishes separate Disproportionate Share Hospital (DSH) reduction pools for low-DSH states and other states, and the distribution of reductions in each pool.
- FYI. // HR Specialist: Compensation & Benefits;May2010, Vol. 5 Issue 5, p8
The article reports that the implementation of the new rules that require certain employees to report medical benefits payments has been postponed by the U.S. Centers for Medicare and Medicaid Services (CMS).
- CMS Issues Proposed Rule for Value-Based Purchasing. // hfm (Healthcare Financial Management);Mar2011, Vol. 65 Issue 3, p11
The article reports on the proposed rule given by the Centers for Medicare & Medicaid Services (CMS) for its value-based purchasing (VBO) program in the U.S.
- Community pharmacy prevails in battle over AMPs. // Chain Drug Review;4/25/2011, Vol. 33 Issue 8, p44
The article reports that the U.S. Centers for Medicare and Medicaid Services has ruled the withdrawal of provisions in the Medicaid pharmacy reimbursement formula under the average manufacturer price (AMP) model.
- Long AMP battle comes to a close. // Chain Drug Review;12/6/2010, Vol. 32 Issue 21, p1
The article reports on the removal of Medicaid pharmacy reimbursement formula provisions under the average manufacturer price (AMP) model by the U.S. Centers for Medicare & Medicaid Services (CMS).
- Gov't Pullback Slams Myriad. Investor's Business Daily // Investors Business Daily;12/31/2013, pA01
9 The Centers for Medicare and Medicaid Services confirmed over the weekend it would pay $1,438 on some of the company's breast-cancer vulnerability tests on Jan. 1 after previously saying it would pay $2,795. Some analysts said the prior reimbursement rate could have been a clerical error, but...